BOSTON, Nov. 12, 2025 /PRNewswire/ -- Modulight Biotherapeutics, developer of novel optogenetic platform for the treatment of neurological disorders, announced today the closing of its Seed funding round raising $12.2 million. The Seed round was led by Jibe Ventures and LocalGlobe, with...
Hence then, the article about modulight biotherapeutics announces 12 million seed funding for novel optogenetic therapy to treat neurological disorders was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.
Read More Details
Finally We wish PressBee provided you with enough information of ( Modulight Biotherapeutics Announces $12 Million Seed Funding for Novel Optogenetic Therapy to Treat Neurological Disorders )
Also on site :
- Blizzard conditions and tornadoes disrupt travel as winter brings frigid reality check back to the US
- Arrowhead Stadium Worker Reveals 'Beautifully Kind' Gesture From Taylor Swift During Chiefs' Christmas Day Game
- Samsung Plans to Bring Google Photos to Samsung AI TV Lineup, Helping Users Relive Their Favorite Memories on the Big Screen